glp-1 drugs insurance coverage Insurer strategies to control costs associated with weight loss Why payers are hesitant to
Description
If that sounds familiar, you are not alone
But if youre planning pregnancy, there are some extra things to think about
In the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results (LEADER) study, the incidence of cardiovascular disease was lower when liraglutide was used in patients with type 2 diabetes [15]
Global demand for GLP-1 receptor agonists is expected to be driven by rising rates of diabetes and obesity
